2025
SJR Q1
JCR Q2 · 3,5
161 matched articles
SCIE
Journal detail
Neuromuscular Disorders
- Publisher
- Elsevier Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0960896618732364
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,915
- Quartile Q1
- H-Index 121
- Cites/doc 2,76
- Docs (3y) 369
- Cites (3y) 951
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,5
- 5Y JIF 3,2
- JCI 0,7
WoS indexes
- SCIE
Subject classification
Categories (SJR)
Areas
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,915 | 3,5 | 3,2 | 0,7 | Q3 | 121 |
| 2024 | Q1 | Q2 | 0,885 | 2,8 | 2,9 | 0,67 | Q3 | 116 |
| 2023 | Q1 | Q2 | 0,824 | 2,7 | 3,2 | 0,66 | Q3 | 116 |
| 2022 | Q1 | Q3 | 0,84 | 2,8 | 3,4 | 0,67 | Q3 | 116 |
| 2021 | Q1 | Q2 | 0,98 | 3,5 | 3,9 | 0,86 | Q2 | 116 |
| 2020 | Q1 | Q2 | 1,405 | 4,3 | 3,7 | 0,85 | Q2 | 116 |
| 2019 | Q1 | Q2 | 1,177 | 3,1 | 2,9 | 0,8 | Q2 | 116 |
| 2018 | — | Q3 | — | 2,6 | 2,9 | 0,71 | Q3 | — |
| 2017 | Q1 | Q3 | 1,337 | 2,5 | 2,7 | 0,77 | Q2 | 116 |
| 2016 | Q1 | Q2 | 1,421 | 3 | 2,9 | — | — | 116 |
| 2015 | Q1 | Q2 | 1,484 | 3,1 | 3,1 | — | — | 116 |
| 2014 | Q1 | Q2 | 1,23 | 2,6 | 2,7 | — | — | 116 |
| 2013 | Q1 | Q2 | 1,414 | 3,1 | 3,1 | — | — | 116 |
| 2012 | Q1 | Q1 | 1,418 | 3,5 | 3,2 | — | — | 116 |
| 2011 | Q1 | Q2 | 1,229 | 2,8 | 2,7 | — | — | 116 |
| 2010 | Q1 | Q2 | 1,424 | 2,8 | 2,6 | — | — | 116 |
| 2009 | — | Q2 | — | 3 | 2,8 | — | — | — |
| 2008 | — | Q2 | — | 2,9 | 3 | — | — | — |
| 2007 | — | Q2 | — | 2,7 | 2,6 | — | — | — |
| 2006 | — | Q2 | — | 2,6 | — | — | — | — |
| 2005 | — | Q1 | — | 3,3 | — | — | — | — |
| 2004 | — | Q2 | — | 3 | — | — | — | — |
| 2003 | — | Q2 | — | 2,9 | — | — | — | — |
| 2002 | — | Q2 | — | 2,6 | — | — | — | — |
| 2001 | — | Q2 | — | 2,5 | — | — | — | — |
| 2000 | — | Q2 | — | 2,7 | — | — | — | — |
| 1999 | — | Q1 | — | 2,7 | — | — | — | — |
| 1998 | — | Q1 | — | 2,6 | — | — | — | — |
| 1997 | — | Q1 | — | 2,4 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CLINICAL NEUROLOGY | SCIE | Q2 | Q3 | 93/296 |
| 2025 | NEUROSCIENCES | SCIE | Q2 | Q3 | 138/330 |
| 2024 | CLINICAL NEUROLOGY | SCIE | Q2 | Q3 | 121/286 |
| 2024 | NEUROSCIENCES | SCIE | Q3 | Q3 | 162/314 |
| 2023 | CLINICAL NEUROLOGY | SCIE | Q2 | Q3 | 112/280 |
| 2023 | NEUROSCIENCES | SCIE | Q3 | Q3 | 158/310 |
| 2022 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 121/212 |
| 2022 | NEUROSCIENCES | SCIE | Q3 | Q3 | 184/272 |
| 2021 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 104/212 |
| 2021 | NEUROSCIENCES | SCIE | Q3 | Q2 | 159/275 |
| 2020 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 63/208 |
| 2020 | NEUROSCIENCES | SCIE | Q2 | Q2 | 102/273 |
| 2019 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 76/204 |
| 2019 | NEUROSCIENCES | SCIE | Q2 | Q3 | 128/272 |
| 2018 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 102/199 |
| 2018 | NEUROSCIENCES | SCIE | Q3 | Q3 | 167/267 |
| 2017 | CLINICAL NEUROLOGY | SCIE | Q3 | Q2 | 108/197 |
| 2017 | NEUROSCIENCES | SCIE | Q3 | Q3 | 170/261 |
| 2016 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 72/194 |
| 2016 | NEUROSCIENCES | SCIE | Q2 | — | 124/259 |
| 2015 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 61/193 |
| 2015 | NEUROSCIENCES | SCIE | Q2 | — | 103/256 |
| 2014 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 77/192 |
| 2014 | NEUROSCIENCES | SCIE | Q3 | — | 143/252 |
| 2013 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 55/194 |
| 2013 | NEUROSCIENCES | SCIE | Q2 | — | 118/252 |
| 2012 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 43/193 |
| 2012 | NEUROSCIENCES | SCIE | Q2 | — | 91/252 |
| 2011 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 69/192 |
| 2011 | NEUROSCIENCES | SCIE | Q2 | — | 121/244 |
| 2010 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 66/185 |
| 2010 | NEUROSCIENCES | SCIE | Q3 | — | 121/239 |
| 2009 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 49/167 |
| 2009 | NEUROSCIENCES | SCIE | Q2 | — | 105/231 |
| 2008 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 45/156 |
| 2008 | NEUROSCIENCES | SCIE | Q2 | — | 91/221 |
| 2007 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 44/146 |
| 2007 | NEUROSCIENCES | SCIE | Q2 | — | 90/211 |
| 2006 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 44/147 |
| 2006 | NEUROSCIENCES | SCIE | Q2 | — | 94/200 |
| 2005 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 21/148 |
| 2005 | NEUROSCIENCES | SCIE | Q2 | — | 63/200 |
| 2004 | NEUROSCIENCES | SCIE | Q2 | — | 62/198 |
| 2003 | NEUROSCIENCES | SCIE | Q2 | — | 62/198 |
| 2002 | NEUROSCIENCES | SCIE | Q2 | — | 67/197 |
| 2001 | NEUROSCIENCES | SCIE | Q2 | — | 65/198 |
| 2000 | NEUROSCIENCES | SCIE | Q2 | — | 59/203 |
| 1999 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 24/132 |
| 1999 | NEUROSCIENCES | SCIE | Q2 | — | 54/201 |
| 1998 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 18/125 |
| 1998 | NEUROSCIENCES | SCIE | Q2 | — | 59/202 |
| 1997 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 17/107 |
| 1997 | NEUROSCIENCES | SCIE | Q2 | — | 54/150 |